E. Ramacciotti, N. Wolosker, P. Puech-Leao, E. A. Zeratti, P. R. Gusson, A. del Giglio and R. F. Franco, “Prevalence of Factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T Polymorphisms in Cancer Patients with and without Venous Thrombosis,” Thrombosis Research, Vol. 109, No. 4, 2003, pp. 171-174. http://dx.doi.org/10.1016/S0049-3848(03)00179-8

has been cited by the following article:

• TITLE: Effect of Factor V Leiden on Thrombosis in Childhood Leukemia

  AUTHORS: Dilara Fatma Akın, Nejat Akar

  KEYWORDS: Thrombosis; Acute Leukemia; Childhood; Factor V Leiden

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.3 No.3, September 16, 2013

  ABSTRACT: Thromboembolism is an important complication in children undergoing therapy for ALL as it has the potential to impact adversely on both their survival and quality of life. The incidence of thrombosis in children with ALL varies between 1.1% and 36.7% and the actual mean is 3.2%. The aim of our study is to review the available reported data on the effect of FVL on thrombotic risk in pediatric patients with acute leukemia.